Panton-Valentine leukocidin (PVL) has been the subject of worldwide attention due to its epidemiological linkage to community-associated meticillin-resistant Staphylococcus aureus (CA-MRSA) (Tristan et al., 2007) . Surveillance data for meticillin-resistant S. aureus (MRSA) has not been reported in Serbia before as the last report was before the splitting of Yugoslavia. We initiated MRSA surveillance in 2008 and report here what is to the best of our knowledge the first finding of PVL-positive MRSA in Serbia. The phenotypic and genotypic characteristics of the isolates and the clinical data related to them are reported in this article and compared to findings in other European and non-European countries.
From January to July 2008, 26 hospitals (mostly acute-care hospitals) in 17 Serbian towns ( Fig. 1) agreed to participate in our study of MRSA in Serbia. One isolate per patient was included in the study. MRSA isolates were confirmed phenotypically by the BD Phoenix automated microbiology system (Becton Dickinson Diagnostic Systems), and by detection of the nuc and mecA genes using PCR (Cirković et al., 2008) . The PMIC/ID-55 ID/AST panel was used for susceptibility testing of MRSA isolates by the BD Phoenix system (Cirković et al., 2008) : amoxicillin/ clavulanic acid, ampicillin, cefoxitin, ciprofloxacin, clindamycin, erythromycin, fusidic acid, gentamicin, gentamicin synergy, kanamycin, linezolid, mupirocin, high-level mupirocin, nitrofurantoin, oxacillin, penicillin, quinupristin/ dalfopristin, rifampicin, teicoplanin, tetracycline, tobramycin, trimethoprim, trimethoprim/sulfamethoxazole and vancomycin. The presence of PVL was determined by a PCR protocol described by Lina et al. (1999) . S. aureus ATCC 49775 was used as the positive control. Determination of SCCmec types I to V was achieved by multiplex PCR (Boye et al., 2007) . Multilocus sequence typing (MLST) and spa typing were performed for all PVL-positive MRSA isolates detected in this study according to methods described elsewhere (Enright et al., 2000; Harmsen et al., 2003) .
In total, 162 MRSA isolates were collected by the 26 participating hospitals, ranging from 1 to 12 isolates per hospital. The presence of PVL genes was demonstrated in four (2.5 %) MRSA isolates. These four isolates were isolated in different hospitals from younger outpatients (mean age 28.5 years) with skin infections, i.e. three (75 %) with furunculosis and one (25 %) with external ear infection. Two isolates were from Belgrade, whereas the other isolates were geographically dispersed (Fig. 1) . MLST typing revealed that three of the isolates belonged to ST152, whereas the remaining one was an ST80 isolate. The three ST152 isolates carried a SCCmec 5, Indjija; 6, Pancevo; 7, Belgrade; 8, Valjevo; 9, Gornji Milanovac; 10, Kragujevac; 11, Zajecar; 12, Cacak; 13, Kraljevo; 14, Krusevac; 15, Nis; 16, Leskovac; 17, Vranje. Black squares indicate ST152-MRSA-V, whereas the white square indicates ST80-MRSA-IV.
type V element, were resistant to the tested aminoglycosides (kanamycin, tobramycin and gentamicin) and had variable resistance to tetracycline, erythromycin and clindamycin, and had different spa types (Table 1 ). The variation in spa types indicated that the isolates were not epidemiologically related as they differed by at least two genetic events. However, the two isolates from Belgrade shared PFGE patterns (data not shown). The ST80 (spa t044) isolate carried a SCCmec IV element, and was resistant to kanamycin, tetracycline and fusidic acid.
The proportion of PVL-positive CA-MRSA isolates was low compared to results from other European studies, where ST80-IV is especially common (Larsen et al., 2008) . We did find one ST80 but none of the emerging ST8-IV t008 : USA300 isolates (Larsen et al., 2007) . Despite the wide dissemination of ST80 in Europe, the Balkan countries have previously been suggested to host a reservoir as ST80 was found in Denmark among refugees from the former Yugoslavia (Larsen et al., 2008) . The finding of a single isolate in our study confirms its presence but not its predominance in Serbia. spa typing data from Ruimy et al. (2008) described a total of 12 spa types among the 21 analysed ST152 isolates (t355, t084, t1149, t1476, t024, t127, t279, t311, t701, t774, t861 and t1215) . In our study we found not only the 'archetype' t355 but also the rarely described t1183 [Ridom database: Sweden and Germany (www.ridom.de)] and t6371, which had not been detected previously. Given this variation in just three isolates it could strengthen the interpretation that ST152 isolates form a large and diverse reservoir in our part of Europe.
A limitation of our study was that the strains were only collected in the year 2008
and that we have not had the opportunity to continue the surveillance thereafter. However, this report serves as a baseline study for future surveillance programs of MRSA in Serbia. 
